Tal Teitz

2.6k total citations · 1 hit paper
31 papers, 1.9k citations indexed

About

Tal Teitz is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, Tal Teitz has authored 31 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 10 papers in Neurology and 9 papers in Oncology. Recurrent topics in Tal Teitz's work include Cell death mechanisms and regulation (12 papers), Neuroblastoma Research and Treatments (10 papers) and Hearing, Cochlea, Tinnitus, Genetics (5 papers). Tal Teitz is often cited by papers focused on Cell death mechanisms and regulation (12 papers), Neuroblastoma Research and Treatments (10 papers) and Hearing, Cochlea, Tinnitus, Genetics (5 papers). Tal Teitz collaborates with scholars based in United States, Israel and Japan. Tal Teitz's co-authors include Vincent J. Kidd, Jill M. Lahti, Virginia Valentine, José Grenet, Elio F. Vanin, A. Thomas Look, Dwayne G. Stupack, David Mikolon, Dan Canaani and Peter J. Houghton and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Tal Teitz

30 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN

2000 623 citations Tal Teitz, Elio F. Vanin et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tal Teitz United States	19	1.5k	484	465	414	277	31	1.9k
Arturo Sala United Kingdom	29	1.6k 1.1×	272 0.6×	1.1k 2.3×	402 1.0×	340 1.2×	55	2.3k
Behnam Nabet United States	22	3.1k 2.1×	95 0.2×	619 1.3×	356 0.9×	237 0.9×	41	3.6k
Elizabeth E. Reczek United States	9	2.1k 1.4×	364 0.8×	1.2k 2.6×	513 1.2×	305 1.1×	10	3.2k
Ronald K. Gary United States	18	1.5k 1.0×	443 0.9×	296 0.6×	235 0.6×	103 0.4×	31	2.1k
Peter J. Hurlin United States	27	1.6k 1.1×	84 0.2×	580 1.2×	296 0.7×	166 0.6×	47	2.0k
Steve Silletti United States	24	1.5k 1.0×	117 0.2×	598 1.3×	705 1.7×	300 1.1×	49	2.8k
Maria-Magdalena Georgescu United States	17	1.8k 1.2×	72 0.1×	339 0.7×	237 0.6×	495 1.8×	29	2.5k
Kersi Pestonjamasp United States	19	1.2k 0.8×	153 0.3×	177 0.4×	104 0.3×	350 1.3×	36	1.9k
Ken Aldape United States	15	1.3k 0.9×	149 0.3×	540 1.2×	743 1.8×	252 0.9×	21	2.4k
Jakob Lovén United States	15	2.5k 1.7×	127 0.3×	435 0.9×	636 1.5×	231 0.8×	17	3.1k

Countries citing papers authored by Tal Teitz

Since Specialization

Citations

This map shows the geographic impact of Tal Teitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tal Teitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tal Teitz more than expected).

Fields of papers citing papers by Tal Teitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tal Teitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tal Teitz. The network helps show where Tal Teitz may publish in the future.

Co-authorship network of co-authors of Tal Teitz

This figure shows the co-authorship network connecting the top 25 collaborators of Tal Teitz. A scholar is included among the top collaborators of Tal Teitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tal Teitz. Tal Teitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ingersoll, Matthew A., et al.. (2024). Trametinib, a MEK1/2 Inhibitor, Protects Mice from Cisplatin- and Noise-Induced Hearing Loss. Pharmaceuticals. 17(6). 735–735.

Ingersoll, Matthew A., et al.. (2024). KSR1 knockout mouse model demonstrates MAPK pathway's key role in cisplatin- and noise-induced hearing loss. Journal of Neuroscience. 44(18). e2174232024–e2174232024. 5 indexed citations

Ingersoll, Matthew A., Regina G. Kelmann, Huizhan Liu, et al.. (2023). Dabrafenib protects from cisplatin-induced hearing loss in a clinically relevant mouse model. JCI Insight. 8(24). 5 indexed citations

Ingersoll, Matthew A., Zhenhang Xu, Marisa Zallocchi, et al.. (2020). BRAF inhibition protects against hearing loss in mice. Science Advances. 6(49). 40 indexed citations

Hazlitt, Robert A., Tal Teitz, Shiyong Diao, et al.. (2018). Development of Second-Generation CDK2 Inhibitors for the Prevention of Cisplatin-Induced Hearing Loss. Journal of Medicinal Chemistry. 61(17). 7700–7709. 26 indexed citations

Xu, Heng, Giles Robinson, Jie Huang, et al.. (2015). Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss. Nature Genetics. 47(3). 263–266. 92 indexed citations

Teitz, Tal, Marcus B. Valentine, Kejin Zhu, et al.. (2013). Th-MYCN Mice with Caspase-8 Deficiency Develop Advanced Neuroblastoma with Bone Marrow Metastasis. Cancer Research. 73(13). 4086–4097. 48 indexed citations

Teitz, Tal, Jennifer J. Stanke, Sara M. Federico, et al.. (2011). Preclinical Models for Neuroblastoma: Establishing a Baseline for Treatment. PLoS ONE. 6(4). e19133–e19133. 70 indexed citations

Barbero, Simone, Ainhoa Mielgo, Vicente A. Torres, et al.. (2009). Caspase-8 Association with the Focal Adhesion Complex Promotes Tumor Cell Migration and Metastasis. Cancer Research. 69(9). 3755–3763. 112 indexed citations

10.

Stupack, Dwayne G., Tal Teitz, David Mikolon, et al.. (2006). Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature. 439(7072). 95–99. 210 indexed citations

11.

Teitz, Tal, Dong Liu, Virginia Valentine, et al.. (2002). Caspase-9 and Apaf-1 are expressed and functionally active in human neuroblastoma tumor cell lines with 1p36 LOH and amplified MYCN. Oncogene. 21(12). 1848–1858. 37 indexed citations

12.

Takita, Junko, Hong Wei Yang, Yuyan Chen, et al.. (2001). Allelic imbalance on chromosome 2q and alterations of the caspase 8 gene in neuroblastoma. Oncogene. 20(32). 4424–4432. 75 indexed citations

13.

Takita, Junko, Hong Yang, Fumio Bessho, et al.. (2000). Absent or reduced expression of thecaspase 8 gene occurs frequently in neuroblastoma, but not commonly in Ewing sarcoma or rhabdomyosarcoma. Medical and Pediatric Oncology. 35(6). 541–543. 33 indexed citations

14.

Kidd, Vincent J., Jill M. Lahti, & Tal Teitz. (2000). Proteolytic regulation of apoptosis. Seminars in Cell and Developmental Biology. 11(3). 191–201. 74 indexed citations

15.

Teitz, Tal, Elio F. Vanin, José Grenet, et al.. (2000). Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nature Medicine. 6(5). 529–535. 623 indexed citations breakdown →

16.

Teitz, Tal, Judy C. Chang, Yuet Wai Kan, & T. S. Benedict Yen. (1995). Thymic epithelial neoplasms in transgenic mice expressing SV40 T antigen under the control of an erythroid‐specific enhancer. The Journal of Pathology. 177(3). 309–315. 5 indexed citations

17.

Teitz, Tal, T. S. Benedict Yen, Judy C. Chang, & Yuet Wai Kan. (1994). SV40 T Antigen Directed by a Powerful Erythroid Enhancer–Promoter Produced Sarcomas and Pancreatic Tumors But Not Erythroid-Specific Tumors in Transgenic Mice. DNA and Cell Biology. 13(7). 705–710. 3 indexed citations

18.

Teitz, Tal, Mary Bakhanashvili, Tova Naiman, et al.. (1990). Expression of the cDNA for the beta subunit of human casein kinase II confers partial UV resistance on xeroderma pigmentosum cells. Mutation Research/DNA Repair. 236(1). 85–97. 52 indexed citations

19.

Teitz, Tal, et al.. (1990). Isolation by polymerase chain reaction of a cDNA whose product partially complements the ultraviolet sensitivity of xeroderma pigmentosum group C cells. Gene. 87(2). 295–298. 20 indexed citations

20.

Yang‐Feng, Teresa L., et al.. (1990). Assignment of the human casein kinase II β-subunit gene to 6p12→p21. Genomics. 8(4). 741–742. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact